Drug price control in Malaysia: a stakeholder analysis

IF 1.8 Q3 HEALTH POLICY & SERVICES International Journal of Health Governance Pub Date : 2021-08-24 DOI:10.1108/ijhg-02-2021-0014
A. Ashraf, S. C. Ong
{"title":"Drug price control in Malaysia: a stakeholder analysis","authors":"A. Ashraf, S. C. Ong","doi":"10.1108/ijhg-02-2021-0014","DOIUrl":null,"url":null,"abstract":"PurposePharmaceutical pricing has always been a contentious issue around the world. Recently, the Government of Malaysia has proposed for drug price control. This proposal has received backlash from pharmaceutical industry. Therefore in this study, the authors would like to examine the position of various stakeholders on this issue.Design/methodology/approachThe authors used Policy Maker software to identify and evaluate the position of the stakeholders, their interest and their power. Next, the authors contextualize the factors that might contribute to the success or failure of the policy using Kingdon's multiple stream analysis.FindingsThe authors found that the drug price control regulation received mixed reactions from the stakeholders, with the public sector mainly supporting the proposal whereas the private sectors opposing it. The findings indicate that the drug price control proposal have a high chance of success due to strong political will from both the government and the opposition and also strong support from the public and the consumer groups.Practical implications1. The drug price control proposal received strong political will and strong public support. Thus, it has a high chance of success. 2. The government should be careful in managing concentrated powerful groups. The government should strategically engage with the stakeholders to move them to more positive attitude. 3. The government should avoid backtracking on policies as this will portray critical weakness to other stakeholders.Social implicationsThe public sector provides strong support for the regulation. However, this support must be maintained and remain as their top priority. Their opinions are important in shaping health policies. The public's feedback will provide transparency and accountability in the policy-making process.Originality/valueThe findings indicate that the drug price control proposal have a high chance of success due to strong political will from both the government and the opposition and also strong support from the public and the consumer groups.","PeriodicalId":42859,"journal":{"name":"International Journal of Health Governance","volume":" ","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2021-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Health Governance","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1108/ijhg-02-2021-0014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 5

Abstract

PurposePharmaceutical pricing has always been a contentious issue around the world. Recently, the Government of Malaysia has proposed for drug price control. This proposal has received backlash from pharmaceutical industry. Therefore in this study, the authors would like to examine the position of various stakeholders on this issue.Design/methodology/approachThe authors used Policy Maker software to identify and evaluate the position of the stakeholders, their interest and their power. Next, the authors contextualize the factors that might contribute to the success or failure of the policy using Kingdon's multiple stream analysis.FindingsThe authors found that the drug price control regulation received mixed reactions from the stakeholders, with the public sector mainly supporting the proposal whereas the private sectors opposing it. The findings indicate that the drug price control proposal have a high chance of success due to strong political will from both the government and the opposition and also strong support from the public and the consumer groups.Practical implications1. The drug price control proposal received strong political will and strong public support. Thus, it has a high chance of success. 2. The government should be careful in managing concentrated powerful groups. The government should strategically engage with the stakeholders to move them to more positive attitude. 3. The government should avoid backtracking on policies as this will portray critical weakness to other stakeholders.Social implicationsThe public sector provides strong support for the regulation. However, this support must be maintained and remain as their top priority. Their opinions are important in shaping health policies. The public's feedback will provide transparency and accountability in the policy-making process.Originality/valueThe findings indicate that the drug price control proposal have a high chance of success due to strong political will from both the government and the opposition and also strong support from the public and the consumer groups.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
马来西亚药品价格管制:利益相关者分析
目的药品定价一直是世界上一个有争议的问题。最近,马来西亚政府提出了控制药品价格的建议。这一提议遭到了制药行业的强烈反对。因此,在本研究中,作者希望考察各利益相关者在这一问题上的立场。设计/方法论/方法作者使用政策制定者软件来识别和评估利益相关者的立场、利益和权力。接下来,作者使用Kingdon的多流分析,将可能导致政策成败的因素置于情境中。研究结果作者发现,利益相关者对药品价格控制法规的反应不一,公共部门主要支持该提案,而私营部门则反对。研究结果表明,由于政府和反对派的强烈政治意愿,以及公众和消费者团体的大力支持,药品价格控制提案成功的几率很高。实际含义1。药品价格控制提案得到了强烈的政治意愿和公众的大力支持。因此,它成功的几率很高。2.政府在管理权力集中的集团时应小心谨慎。政府应战略性地与利益相关者接触,促使他们采取更积极的态度。3.政府应避免在政策上倒退,因为这会给其他利益相关者带来严重的弱点。社会影响公共部门为监管提供了强有力的支持。然而,必须保持这种支持,并将其作为他们的首要任务。他们的意见对制定卫生政策很重要。公众的反馈将为决策过程提供透明度和问责制。原创性/价值研究结果表明,由于政府和反对派的强烈政治意愿,以及公众和消费者团体的大力支持,药品价格控制提案很有可能成功。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
International Journal of Health Governance
International Journal of Health Governance HEALTH POLICY & SERVICES-
CiteScore
3.30
自引率
15.40%
发文量
28
期刊介绍: International Journal of Health Governance (IJHG) is oriented to serve those at the policy and governance levels within government, healthcare systems or healthcare organizations. It bridges the academic, public and private sectors, presenting case studies, research papers, reviews and viewpoints to provide an understanding of health governance that is both practical and actionable for practitioners, managers and policy makers. Policy and governance to promote, maintain or restore health extends beyond the clinical care aspect alone.
期刊最新文献
The response of regional general hospitals in Indonesia to COVID-19 Editorial: Time to treat the climate and nature crisis as one indivisible global health emergency IJHG review 28.4 Management of gallstone disease and chronic liver diseases during the COVID-19 outbreak in Ukraine: an ecological study Transforming food systems: a case of Eat Right India
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1